Kura Oncology Announces Publication Of Manuscript In Blood, Journal Of The American Society Of Hematology, Detailing Discovery And Preclinical Development Of Ziftomenib
– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action –– Findings demonstrate differentiated menin binding and activity against
Kura Oncology shared scientific details about a medicine it's developing, showing it works in lab tests. This kind of published research helps doctors and scientists understand the medicine better, which is a normal step before testing it in real patients.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.